Latest Production News

Carnaby Resources has reported a game-changing drill result at its Trek 1 prospect, intersecting 7m at 9.3% copper equivalent, significantly extending known mineralisation beyond the current resource estimate.

Barton Gold Holdings has been added to the S&P Dow Jones ASX All Ordinaries Index, marking its rise among Australia's top 500 companies. The company is accelerating development of its South Australian gold projects, targeting significant production milestones by 2026.

Starpharma has entered a significant collaboration with Genentech to develop dendrimer-drug conjugates for oncology, securing an upfront payment and potential milestone earnings exceeding half a billion dollars.

Andromeda Metals has responded to ASX queries regarding its commissioned East Coast Research report, clarifying compliance with disclosure rules and differences in project assumptions.

Nex Metals Explorations has secured a binding agreement to operate the North Hennai gold project in Egypt’s Eastern Desert, marking its strategic entry into one of the world’s most under-explored mining regions with promising production and exploration potential.

Starpharma has entered a landmark collaboration with Genentech to develop innovative cancer therapies using its proprietary DEP® platform, securing $5.5 million upfront and potential milestones exceeding $560 million.

Hastings Technology Metals and Wyloo have formalised their joint venture for the Yangibana Rare Earths Project, with Wyloo taking a 60% stake and cancelling A$123 million in exchangeable notes, significantly de-risking the project and reducing Hastings’ funding burden.

Santana Minerals has reported a significant high-grade gold intercept extending the Rise and Shine deposit 250 metres down plunge, suggesting a potentially much larger orebody and longer mine life.

LTR Pharma has acquired a one-third equity stake in LevOmega Pty Ltd at no cost to shareholders, positioning itself in the growing pharmaceutical-grade omega-3 sector. This strategic move complements LTR’s existing intranasal pharmaceutical portfolio and aligns with its innovation-driven growth strategy.

Pacgold Limited has launched an extensive exploration campaign at its St George Gold-Antimony Project in Queensland, deploying soil sampling and geophysical surveys ahead of planned drilling.

Ballard Mining reports strong infill drilling results at its Baldock gold deposit, confirming and refining a high-grade resource and targeting a maiden reserve by mid-2026. The ongoing program highlights potential resource growth beyond current estimates.

Locksley Resources reports robust metallurgical testwork from its Mojave Project, confirming high antimony recoveries and concentrate grades that support a domestic US supply chain. The results align with US strategic priorities for critical mineral independence.